TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical models
Irie, Hiroki; Ito, Kimihiro; Fujioka, Yayoi; Oguchi, Kei; Fujioka, Akio; Hashimoto, Akihiro; Ohsawa, Hirokazu; Tanaka, Kenji; Funabashi, Kaoru; Araki, Hikari; Kawai, Yuichi; Shimamura, Tadashi; Wadhwa, Renu; Ohkubo, Shuichi; Matsuo, Kenichi
- 期刊名称Molecular Cancer Therapeutics
- 作者Irie, Hiroki; Ito, Kimihiro; Fujioka, Yayoi; Oguchi, Kei; Fujioka, Akio; Hashimoto, Akihiro; Ohsawa, Hirokazu; Tanaka, Kenji; Funabashi, Kaoru; Araki, Hikari; Kawai, Yuichi; Shimamura, Tadashi; Wadhwa, Renu; Ohkubo, Shuichi; Matsuo, Kenichi
- 印刷ISSN1535-7163
- 电子ISSN1538-8514
- 文件大小5530.46KB
- 发表时间2019-02-20
- DOI10.1158/1535-7163.MCT-18-1085